NCT06493162

Brief Summary

Flow-Controlled Ventilation is designed to ventilate the patient with constant flows during both inspiration and expiration. During inspiration, the pressure rises linearly from a set positive end-expiratory pressure (PEEP) to a set positive inspiratory pressure (PIP), and then falls linearly from PIP to end-expiratory pressure (EEP) during expiration. There are no flow interruptions during the Flow-Controlled Ventilation cycle, and the rate of change of pressure and volume in the lungs is equal, allowing for higher tidal volumes at lower pressures. The user sets the inspiratory flow rate and the ratio of inspiratory to expiratory time, providing full control over the ventilation cycle. However, this results in two unusual features: During inspiration, the ventilator creates positive pressure to direct gas into the patient's lungs through the endotracheal tube (ETT). When the intratracheal pressure (airway pressure) reaches the set PIP value, the ventilator switches from inspiration to expiration. By reversing the flow, it utilizes the Bernoulli effect to create negative pressure, facilitating expiration. Despite the presence of negative pressure on the ventilator side, the pressure in the patient's airway remains positive at all times. Volume-controlled ventilation is a mode that is volume-controlled, time-cycled, time-triggered, and pressure-limited. In volume-controlled ventilation, high pressures are sometimes necessary to reach the target tidal volume. This can lead to barotrauma, atelectrauma, and volutrauma in the lungs. Therefore, to avoid high pressures, low tidal volume ventilation is preferred. For Microscopic Laryngeal Surgeries, patients are intubated with a small sized endotracheal tube which results with higher pressures. We think that flow controlled ventilation will improve the ventilation during the surgery with lower pressures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 9, 2024

Completed
23 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1.5 years

First QC Date

June 29, 2024

Last Update Submit

February 25, 2026

Conditions

Keywords

Microscopic Laryngeal SurgeryFlow Controlled VentilationVolume Controlled Ventilation

Outcome Measures

Primary Outcomes (5)

  • PIP

    Peak inspiratory pressure

    10 minutes interval after the intubation during the surgery

  • RR

    Respiratory rate

    10 minutes interval after the intubation during the surgery

  • TV

    Tidal volume

    10 minutes interval after the intubation during the surgery

  • Compliance (Cdyn)

    Dynamic compliance (ventilator calculates: Cdyn = tidal volume/(PIP - PEEP)

    10 minutes interval after the intubation during the surgery

  • Resistance

    Resistance (ventilator calculates: dividing the \[peak pressure minus the plateau pressure\] by the flowrate in litres per second)

    10 minutes interval after the intubation during the surgery

Secondary Outcomes (3)

  • HR

    10 minutes interval after the intubation during the surgery

  • MP

    10 minutes interval after the intubation during the surgery

  • SpO2

    10 minutes interval after the intubation during the surgery

Study Arms (2)

FCV Group

ACTIVE COMPARATOR

Patients who will be ventilated with flow controlled ventilation following the intubation

Procedure: IntubationDevice: Flow Controlled Ventilation

VCV Group

ACTIVE COMPARATOR

Patients who will be ventilated with volume controlled ventilation following the intubation

Procedure: IntubationDevice: Volume Controlled Ventilation

Interventions

IntubationPROCEDURE

Patients will be intubated with 5mm sized endotracheal tube for microscopic laryngeal surgery

FCV GroupVCV Group

Patients in FCV group will be ventilated with flow controlled ventilation mode

FCV Group

Patients in VCV group will be ventilated with volume controlled ventilation mode

VCV Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who undergo elective microscopic laser surgery
  • ASA status I and II

You may not qualify if:

  • Surgery time more than 2 hours
  • Patients with difficult intubation
  • Patients with chronic lung diseases
  • BMI \> 25

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University

Kocaeli, 41350, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Intubation

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 29, 2024

First Posted

July 9, 2024

Study Start

August 1, 2024

Primary Completion

January 15, 2026

Study Completion

February 1, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations